- Home
- Publications
- Publication Search
- Publication Details
Title
Defining response to anti-VEGF therapies in neovascular AMD
Authors
Keywords
-
Journal
EYE
Volume 29, Issue 6, Pages 721-731
Publisher
Springer Nature
Online
2015-04-17
DOI
10.1038/eye.2015.48
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
- (2014) C Ehlken et al. EYE
- The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
- (2014) OPHTHALMOLOGY
- The Neovascular Age-Related Macular Degeneration Database
- (2014) Javier Zarranz-Ventura et al. OPHTHALMOLOGY
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK
- (2013) Tiarnan D L Keenan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration
- (2013) Ilse Krebs et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab
- (2013) Arghavan Almony et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary
- (2013) U Chakravarthy et al. EYE
- Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010
- (2013) Salomon Y. Cohen et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration
- (2013) Annette Rasmussen et al. OPHTHALMOLOGY
- Pharmacogenetic Associations with Vascular Endothelial Growth Factor Inhibition in Participants with Neovascular Age-related Macular Degeneration in the IVAN Study
- (2013) Andrew J. Lotery et al. OPHTHALMOLOGY
- Current Anti–Vascular Endothelial Growth Factor Dosing Regimens
- (2013) Julia A. Haller OPHTHALMOLOGY
- Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)
- (2013) Stephanie A. Hagstrom et al. OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- POLYPOIDAL CHOROIDAL VASCULOPATHY
- (2013) Adrian H.C. Koh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Time Trends in the Incidence and Causes of Blindness in Israel
- (2012) Alon Skaat et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
- (2012) Sara Brandi Bloch et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration
- (2012) Jonathan H. Lim et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling?
- (2012) E Rostron et al. EYE
- Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid
- (2012) A T Fung et al. EYE
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg Intravitreal Ranibizumab for Recalcitrant Neovascular Macular Degeneration–Primary End Point
- (2012) David M. Brown et al. OPHTHALMOLOGY
- Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
- (2012) Gui-shuang Ying et al. OPHTHALMOLOGY
- EVEREST STUDY
- (2012) Adrian Koh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration
- (2012) Seenu M. Hariprasad et al. Journal of Ophthalmology
- Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact
- (2011) Gary Shienbaum et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
- (2011) Julie L Gasperini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
- (2011) Maria Salling Eghøj et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy
- (2011) J. R. de Oliveira Dias et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications
- (2011) S P Kelly et al. EYE
- Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12
- (2011) T A Williams et al. EYE
- Retreatment criteria in anti-VEGF therapy of exudative AMD: critical analysis of present regimes and new morphological definition of “lesion activity”
- (2011) Daniel Pauleikhoff et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
- (2011) Usha Chakravarthy et al. BMC Ophthalmology
- Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity
- (2010) Philipp Sebastian Muether et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Frühzeitige Behandlung mit Ranibizumab (Lucentis®) bei exsudativer AMD
- (2010) E. Matthé et al. OPHTHALMOLOGE
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact
- (2010) Omesh P. Gupta et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED
- (2010) Hassiba Oubraham et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Tachyphylaxis and Bevacizumab
- (2009) Konstantinos N. Avgikos et al. OPHTHALMOLOGY
- Bevacizumab Tachyphylaxis
- (2009) Khalil Ghasemi Falavarjani et al. OPHTHALMOLOGY
- TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2009) FARZIN FOROOGHIAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Ranibizumab: The clinician's guide to commencing, continuing and discontinuing treatment
- (2008) W Amoaku EYE
- Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
- (2008) L Arias et al. EYE
- Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
- (2008) Shlomit Schaal et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started